The lung microbiome in lung transplantation

J Heart Lung Transplant. 2021 Aug;40(8):733-744. doi: 10.1016/j.healun.2021.04.014. Epub 2021 May 7.

Abstract

Culture-independent study of the lower respiratory tract after lung transplantation has enabled an understanding of the microbiome - that is, the collection of bacteria, fungi, and viruses, and their respective gene complement - in this niche. The lung has unique features as a microbial environment, with balanced entry from the upper respiratory tract, clearance, and local replication. There are many pressures impacting the microbiome after transplantation, including donor allograft factors, recipient host factors such as underlying disease and ongoing exposure to the microbe-rich upper respiratory tract, and transplantation-related immunosuppression, antimicrobials, and postsurgical changes. To date, we understand that the lung microbiome after transplant is dysbiotic; that is, it has higher biomass and altered composition compared to a healthy lung. Emerging data suggest that specific microbiome features may be linked to host responses, both immune and non-immune, and clinical outcomes such as chronic lung allograft dysfunction (CLAD), but many questions remain. The goal of this review is to put into context our burgeoning understanding of the lung microbiome in the postlung transplant patient, the interactions between microbiome and host, the role the microbiome may play in post-transplant complications, and critical outstanding research questions.

Keywords: chronic lung allograft dysfunction; hostmicrobe interactions; lung microbiome; lung transplantation.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Dysbiosis / etiology
  • Dysbiosis / microbiology*
  • Humans
  • Lung / microbiology*
  • Lung Transplantation / adverse effects*
  • Microbiota*